南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

抗癌药物cephalotaxinone和homoerythratine的完全生物合成

Complete biosynthesis of the anticancer cephalotaxinone and homoerythratine

Runze Tian, Feifan Lin, Nianxin Guo, Chendi Liu, Kaiqi Chen, Yunxi Han, Ruiyun Lan, Qiang Li, Jianbin Yan, Xiaoguang Lei

Journal:CELL

IF:45.1

DOI:10.1016/j.cell.2026.06.007

PMID:

Published:2026-06-11

research field:天然产物生物合成细胞色素P450酶学代谢工程生物碱化学植物生物化学多组学整合

Abstract

Cephalotaxine-type and homoerythrina-type alkaloids are structurally unique and biologically important natural products isolated from endangered species that belong to the genus Cephalotaxus. Among them, homoharringtonine (HHT [1]) is a marketed drug used to treat leukemia. However, the scalable production of HHT is significantly hindered by limited natural resources. Despite intensive investigation over half a century, the complete biosynthetic pathways of these alkaloids remain unknown. Here, we applied a comprehensive multi-omics analysis and used a set of chemically synthesized standard compounds to identify the missing enzymes required for the biosynthesis of cephalotaxinone and homoerythratine. We also uncovered a rare case of divergent oxidation catalyzed by two highly homologous cytochrome P450 enzymes, CfCYP2 and CfCYP3, in the biosynthesis of two structurally distinct alkaloids. We further identified the key residues that significantly affect the divergent oxidation outcomes and ultimately reconstituted the complete biosynthetic pathways for producing these two alkaloids in N. benthamiana.

本文使用的Yeasen产品

购物车
客服
转染试用